Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy

Tripathy, Koushik; Chaudhuri, Arpan

doi:10.4103/ijo.ijo_1654_18

Indian J Ophthalmol

2019

DOI: 10.4103/ijo.ijo_1654_18

|View full text |Cite

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy

Koushik Tripathy

Arpan Chaudhuri

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We would like to thank the authors for their interest in the article[1] and valuable comments. [2] Point wise response to the author's queries is as follows:…”

mentioning

confidence: 99%

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy

Padhi

Kumar

2019

Indian J Ophthalmol

View full text Add to dashboard Cite

“…We would like to thank the authors for their interest in the article[1] and valuable comments. [2] Point wise response to the author's queries is as follows:…”

mentioning

confidence: 99%

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy

Padhi

Kumar

2019

Indian J Ophthalmol

View full text Add to dashboard Cite

Hypertensive retinopathy: clinical aspects

Dotsenko

Shekhunova

Boev

et al. 2022

View full text Add to dashboard Cite

Funduscopic examination has long been recognized as the most affordable way to assess the condition of small diameter vessels. However, accumulation of new research data, changes in the requirements for the management of patients with various diseases require a return to the clinical, prognostic significance of fundoscopy and the specification of indications for its conduction in certain situations. This article discusses the prevalence of retinopathy depending on the etiological factor, criteria and stages of its development. Until now, a number of issues regarding retinopathy have not been finally resolved, in particular the classification optimal for routine practice, method of its study, etc. It is believed that changes in the fundus blood vessels reflect parallel changes in the vessels of other regions, but this is not always so. A moderate prognostic value of “mild” retinopathy has been established in terms of the risk of cardiovascular diseases, with moderate retinopathy, this relationship reaches a strong level, and with a malignant one, there is a strong correlation with death. The article discusses indications for fundoscopy in routine clinical practice, taking into account the latest scientific data and international recommendations. For the treatment of hypertensive retinopathy, only adequate control of blood pressure is recommended, which can reduce the signs of retinopathy. The authors concluded that the prognostic value of stage 1–2 hypertensive retinopathy is minimal and does not affect patient management. The latter eliminates the need for fundoscopy in patients with mild, controlled arterial hypertension, not suffering from diabetes, with the exception of young patients. Fundoscopy is required in patients with difficult-to-control and resistant arterial hypertension, high variability of blood pressure.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy

Cited by 2 publications

References 5 publications

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy

Hypertensive retinopathy: clinical aspects

Contact Info

Product

Resources

About